Thus, we hypothesized that targeting downstream signaling steps with SIK inhibitors might induce 1,25-vitamin D stimulation, even in the setting of early-stage kidney injury, by bypassing defects due to PTH receptor downregulation and high serum levels of FGF23. Here, SIK1 is linked to injury.